What Bond's Jerusalem deal is actually worth

On August 27th Bond signed what it calls a definitive citywide agreement with the mayor of Jerusalem, Moshe Lion, to protect all 10,000 of the city's municipal workers, beginning with social workers who are already being onboarded. The contract is real: signed, named and partly executed. The question for anyone tempted to read the headline as a reason to buy the stock is what it is worth. Run the arithmetic and the answer is surprisingly small; run the balance-sheet arithmetic and the market's verdict becomes legible.

Bond — Our Bond, Inc., trading on Nasdaq as OBAI — sells personal security as a subscription. An app links the user to a command centre staffed with human agents and, in some packages, a first-responder drone service. Its founder, Doron Kempel, built SimpliVity, a storage firm later acquired by Hewlett Packard Enterprise — a track record rare for a microcap. What is unusual is the route to public markets. Bond listed on February 4th by direct listing, selling no new shares and taking no money. The paper offered for resale belonged to existing owners, many of them retail investors from crowdfunding rounds. The market capitalised the company at $457m on day one; it is now worth under $10m, its shares changing hands near 30 cents.

Today's contract was flagged in June, when Bond announced a citywide deal covering the 10,000 employees of an unnamed city of more than a million residents. The unnamed city now has a mayor's signature. What it still lacks is a price. Bond's most recent disclosed comparable is its own: $250,000 a year to protect 5,000 employees of a global pharmaceutical firm, about $50 per worker. At that price, Jerusalem's 10,000 municipal workers bring in roughly $500,000 a year — five per cent of the $9.97m of revenue Bond reported for 2025. Even at double the price the agreement adds under a tenth of annual sales. And a licence is not yet a revenue: onboarding has begun, but fees follow adoption, and municipal money follows budgets.

The market has already done this arithmetic. Revenue has not grown into the story: it rose just over two per cent in 2025 and fell seven per cent, year on year, in the second quarter of 2026. The losses are the heavier problem. Bond lost $10.5m in all of 2025; in the first half of 2026 it lost $11.5m and warned that doubts exist about its ability to continue as a going concern. Cash at the end of June stood at $5.2m — barely more than the $4.8m lost in the quarter alone. Even an improving report was read as bad news: the shares fell 24 per cent on the day the company announced a narrower loss and cheaper operations.

To be sure, the case for taking the announcements seriously has strengthened. In June an Israeli municipality bought Bond licences for all of its roughly 270,000 residents, the first citywide order for the company's "government-to-consumer" channel, which the chief executive calls a multi-million-dollar revenue opportunity this year. The local press identifies the buyer as the city of Petah Tikva. In February a city that had piloted the service certified Bond as a sole supplier, letting it avoid a competitive tender. Corporations have followed: a pharmaceutical giant now paying for thousands of its staff, and an employer weighing protection for more than a million American workers. In July an EY-Parthenon study, commissioned by Bond, put the platform's benefit at up to $280 per employee a year. The pitch is that personal security has become a municipal service — one a mayor can hand out like a badge.

The trouble is that every success makes the balance sheet more, not less, central. In June investors converted $3.3m of debt into equity at $2.03 a share, which the company described as a premium of more than 200 per cent to the market price and which was, on any view, a small fraction of the price at which the company had begun trading. A registration statement in April covered 7.1m shares tied to a $300m equity line from Ascent Partners, a facility that would fund Bond by feeding more paper into the market. In July Nasdaq told the company that its share price, public float and the value of its listed securities all fall short of listing standards; it has 180 days to comply. An authorised capital of 200m shares against about 30m outstanding leaves ample room for the remedies a sub-dollar stock typically needs.

None of this makes the Jerusalem agreement worthless, and dismissing it would be as large an error as celebrating it. A flagship public-sector client has genuine value: it helps Bond sell the next city and negotiate its next capital round from strength. But that value accrues to the company's survival and its fundraising, not to the revenue the headline implies. Two figures would settle the argument — the per-worker price Jerusalem is paying, and the terms of the next raise. Until they appear, the signature is best read as an asset in the one negotiation that matters for shareholders: how much of the remaining value is given away to stay listed. The contract is real. The arithmetic is still in the future tense.